Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up.

Vogelzang EH, Kneepkens EL, Nurmohamed MT, van Kuijk AW, Rispens T, Wolbink G, Krieckaert CL.

Ann Rheum Dis. 2014 Aug 12. pii: annrheumdis-2014-205554. doi: 10.1136/annrheumdis-2014-205554. [Epub ahead of print]

PMID:
25115447
[PubMed - as supplied by publisher]
2.

Rheumatoid arthritis and metabolic syndrome.

Kerekes G, Nurmohamed MT, González-Gay MA, Seres I, Paragh G, Kardos Z, Baráth Z, Tamási L, Soltész P, Szekanecz Z.

Nat Rev Rheumatol. 2014 Aug 5. doi: 10.1038/nrrheum.2014.121. [Epub ahead of print] Review.

PMID:
25090948
[PubMed - as supplied by publisher]
3.

Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis.

van Denderen JC, Visman IM, Nurmohamed MT, Suttorp-Schulten MS, van der Horst-Bruinsma IE.

J Rheumatol. 2014 Sep;41(9):1843-8. doi: 10.3899/jrheum.131289. Epub 2014 Aug 1.

PMID:
25086071
[PubMed - in process]
4.

Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.

Kneepkens EL, Krieckaert CL, van der Kleij D, Nurmohamed MT, van der Horst-Bruinsma IE, Rispens T, Wolbink GJ.

Ann Rheum Dis. 2014 May 7. doi: 10.1136/annrheumdis-2014-205213. [Epub ahead of print]

PMID:
24812290
[PubMed - as supplied by publisher]
5.

Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis.

Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT.

Semin Arthritis Rheum. 2014 Aug;44(1):14-9. doi: 10.1016/j.semarthrit.2014.02.004. Epub 2014 Feb 14.

PMID:
24655534
[PubMed - in process]
6.

Biologics, cardiovascular effects and cancer.

Damjanov N, Nurmohamed MT, Szekanecz Z.

BMC Med. 2014 Mar 18;12:48. doi: 10.1186/1741-7015-12-48. Review.

PMID:
24642038
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Is atherosclerosis an autoimmune disease?

Matsuura E, Atzeni F, Sarzi-Puttini P, Turiel M, Lopez LR, Nurmohamed MT.

BMC Med. 2014 Mar 18;12:47. doi: 10.1186/1741-7015-12-47. Review.

PMID:
24642015
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al.

Nurmohamed MT, Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I.

Ann Rheum Dis. 2014 May;73(5):e28. doi: 10.1136/annrheumdis-2014-205174. Epub 2014 Feb 27. No abstract available.

PMID:
24577335
[PubMed - indexed for MEDLINE]
9.

Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study.

van Sijl AM, Boers M, Voskuyl AE, Nurmohamed MT.

PLoS One. 2014 Jan 30;9(1):e87965. doi: 10.1371/journal.pone.0087965. eCollection 2014.

PMID:
24498229
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system.

van den Oever IA, Sattar N, Nurmohamed MT.

Ann Rheum Dis. 2014 Jun;73(6):954-7. doi: 10.1136/annrheumdis-2013-204767. Epub 2014 Jan 15.

PMID:
24431395
[PubMed - indexed for MEDLINE]
11.

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Boumpas D, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Rainer F, Pavelka K, Chartier M, Poncet C, Rauch C, Bars ML.

BMC Musculoskelet Disord. 2014 Jan 11;15:14. doi: 10.1186/1471-2474-15-14.

PMID:
24410774
[PubMed - in process]
Free PMC Article
12.

Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study.

Ursum J, Nielen MM, Twisk JW, Peters MJ, Schellevis FG, Nurmohamed MT, Korevaar JC.

BMC Fam Pract. 2013 Dec 23;14:199. doi: 10.1186/1471-2296-14-199.

PMID:
24364915
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up.

Kneepkens EL, Wei JC, Nurmohamed MT, Yeo KJ, Chen CY, van der Horst-Bruinsma IE, van der Kleij D, Rispens T, Wolbink G, Krieckaert CL.

Ann Rheum Dis. 2013 Dec 10. doi: 10.1136/annrheumdis-2013-204185. [Epub ahead of print]

PMID:
24326011
[PubMed - as supplied by publisher]
14.

Key findings towards optimising adalimumab treatment: the concentration-effect curve.

Pouw MF, Krieckaert CL, Nurmohamed MT, van der Kleij D, Aarden L, Rispens T, Wolbink G.

Ann Rheum Dis. 2013 Dec 10. doi: 10.1136/annrheumdis-2013-204172. [Epub ahead of print]

PMID:
24326008
[PubMed - as supplied by publisher]
15.

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.

Krieckaert CL, Nair SC, Nurmohamed MT, van Dongen CJ, Lems WF, Lafeber FP, Bijlsma JW, Koffijberg H, Wolbink G, Welsing PM.

Ann Rheum Dis. 2013 Nov 21. doi: 10.1136/annrheumdis-2013-204101. [Epub ahead of print]

PMID:
24265411
[PubMed - as supplied by publisher]
16.

Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis.

van Sijl AM, van Eijk IC, Peters MJ, Serné EH, van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT.

Ann Rheum Dis. 2013 Oct 3. doi: 10.1136/annrheumdis-2013-203934. [Epub ahead of print]

PMID:
24092419
[PubMed - as supplied by publisher]
17.

Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients.

Raterman HG, Voskuyl AE, Simsek S, Schreurs MW, van Hoogstraten IM, Peters MJ, van Halm VP, Dijkmans BA, Lips P, Lems WF, Nurmohamed MT.

Eur J Endocrinol. 2013 Oct 21;169(6):751-7. doi: 10.1530/EJE-13-0394. Print 2013 Dec.

PMID:
24005313
[PubMed - indexed for MEDLINE]
18.

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.

van den Oever IA, van Sijl AM, Nurmohamed MT.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):166-81. doi: 10.1177/1759720X13491025.

PMID:
23904862
[PubMed]
Free PMC Article
19.

Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.

Blits M, Jansen G, Assaraf YG, van de Wiel MA, Lems WF, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Wolbink GJ, Vosslamber S, Verweij CL.

Arthritis Rheum. 2013 Nov;65(11):2791-802. doi: 10.1002/art.38094.

PMID:
23897011
[PubMed - indexed for MEDLINE]
20.

Prevalence of chronic diseases at the onset of inflammatory arthritis: a population-based study.

Ursum J, Korevaar JC, Twisk JW, Peters MJ, Schellevis FG, Nurmohamed MT, Nielen MM.

Fam Pract. 2013 Dec;30(6):615-20. doi: 10.1093/fampra/cmt037. Epub 2013 Jul 20.

PMID:
23873902
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk